FRM
ETNB

Fox Run Management’s 89bio ETNB Stock Holding History

Fox Run Management’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-27,604
Closed -$221K – 883
2024
Q2 		$221K Buy
27,604
+15,402
+126% +$138K 0.04% 644
2024
Q1 		$142K Buy
+12,202
New +$135K 0.03% 679
2023
Q1 		– Sell
-10,053
Closed -$128K – 739
2022
Q4 		$128K Buy
+10,053
New +$90.4K 0.05% 543

Other funds holding ETNB

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Fox Run Management's ETNB Position: Q3 2024 in Review

Fox Run Management sold out of 89bio (ETNB) in Q3 2024, closing a stake of 27,604 shares — an estimated $221K sold.

Fox Run Management first reported a position in ETNB in Q4 2022 and held it in 3 quarters. The position peaked at $221K in Q2 2024. 144 funds tracked by Wall St. Rank hold ETNB as of Q3 2024.

  • Fox Run Management reported no remaining 89bio position as of Q3 2024 after selling out during the quarter.
  • Fox Run Management sold 27,604 89bio shares in Q3 2024, an estimated $221K.
  • Fox Run Management first reported a position in 89bio in Q4 2022 and held it in 3 quarters.
  • Fox Run Management's 89bio position peaked at $221K in Q2 2024.
  • 144 funds tracked by Wall St. Rank held 89bio as of Q3 2024.

Based on Fox Run Management's 13F filing for Q3 2024, filed 12 Nov 2024.